- Home
- RYTM vs LAZ Comparison
RYTM vs LAZ Comparison
Compare RYTM & LAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- LAZ
- Stock Information
- Founded
- RYTM 2008
- LAZ 1848
- Country
- RYTM United States
- LAZ United States
- Employees
- RYTM N/A
- LAZ N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- LAZ Investment Managers
- Sector
- RYTM Health Care
- LAZ Finance
- Exchange
- RYTM Nasdaq
- LAZ Nasdaq
- Market Cap
- RYTM 3.8B
- LAZ 4.1B
- IPO Year
- RYTM 2017
- LAZ 2005
- Fundamental
- Price
- RYTM $57.38
- LAZ $42.54
- Analyst Decision
- RYTM Strong Buy
- LAZ Hold
- Analyst Count
- RYTM 12
- LAZ 7
- Target Price
- RYTM $75.42
- LAZ $46.83
- AVG Volume (30 Days)
- RYTM 671.0K
- LAZ 1.1M
- Earning Date
- RYTM 05-07-2025
- LAZ 04-25-2025
- Dividend Yield
- RYTM N/A
- LAZ 4.72%
- EPS Growth
- RYTM N/A
- LAZ N/A
- EPS
- RYTM N/A
- LAZ 2.87
- Revenue
- RYTM $136,863,000.00
- LAZ $2,939,019,000.00
- Revenue This Year
- RYTM $43.84
- LAZ N/A
- Revenue Next Year
- RYTM $65.62
- LAZ $12.53
- P/E Ratio
- RYTM N/A
- LAZ $14.74
- Revenue Growth
- RYTM 48.88
- LAZ 7.18
- 52 Week Low
- RYTM $35.17
- LAZ $31.97
- 52 Week High
- RYTM $68.58
- LAZ $61.14
- Technical
- Relative Strength Index (RSI)
- RYTM 43.00
- LAZ 57.86
- Support Level
- RYTM $62.69
- LAZ $39.71
- Resistance Level
- RYTM $65.53
- LAZ $43.63
- Average True Range (ATR)
- RYTM 3.04
- LAZ 1.62
- MACD
- RYTM -0.73
- LAZ 0.84
- Stochastic Oscillator
- RYTM 1.14
- LAZ 87.10
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About LAZ Lazard Inc.
Lazard has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.